Naval Daver
MD
Professor, Department of Leukemia
👥Biography 个人简介
Naval Daver is a prolific clinical researcher in AML therapeutics who has led numerous early-phase trials of novel agents including menin inhibitors. His work on immunotherapy combinations in AML, including CD47-targeting and checkpoint inhibition, has opened new treatment paradigms. He has contributed significantly to understanding optimal sequencing of targeted and immune therapies in myeloid malignancies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Naval Daver 的研究动态
Follow Naval Daver's research updates
留下邮箱，当我们发布与 Naval Daver（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment